# Asia Africa Streptokinase Trial

> **NCT02150785** · PHASE2 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Streptokinase

## Key facts

- **NCT ID:** NCT02150785
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Could not get study started.
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02150785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02150785, "Asia Africa Streptokinase Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02150785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*